{"id":"NCT04891419","sponsor":"Allergan","briefTitle":"JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population","officialTitle":"A Multicenter, Evaluator-blinded, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-07-20","primaryCompletion":"2023-11-22","completion":"2023-11-22","firstPosted":"2021-05-18","resultsPosted":"2024-12-12","lastUpdate":"2024-12-12"},"enrollment":168,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Temple Hollowing"],"interventions":[{"type":"DEVICE","name":"JUVÉDERM® VOLUMA® with Lidocaine","otherNames":[]}],"arms":[{"label":"JUVÉDERM® VOLUMA® with Lidocaine","type":"EXPERIMENTAL"},{"label":"Control- No treatment","type":"NO_INTERVENTION"}],"summary":"The objectives of this study are to evaluate the safety and effectiveness of JUVÉDERM® VOLUMA® with Lidocaine injectable gel in adult Chinese population seeking correction of temple hollowing.","primaryOutcome":{"measure":"Number of Participants With Adverse Events","timeFrame":"Up to 14 Months","effectByArm":[{"arm":"Control No-Treatment (Months 1 to 6) to JUVÉDERM® VOLUMA® With Lidocaine Treatment (Months 7 to 12)","deltaMin":23,"sd":null},{"arm":"JUVÉDERM® VOLUMA® With Lidocaine (Treatment Months 1 - 12)","deltaMin":59,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":23},"locations":{"siteCount":8,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":56},"commonTop":["COVID-19","INJECTION SITE PAIN","TRISMUS","INJECTION SITE SWELLING","UPPER RESPIRATORY TRACT INFECTION"]}}